Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

NCT00391638 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

56

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis B
HIV Infections

Interventions

DRUG: TRUVADA (EMTRICITABINE + TENOFOVIR DF)
BIOLOGICAL: PEGASYS 180μg (Interféron pégylé alpha -2a)

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]
[object Object]